Deprescribing for Older Adults in the Community: Recent Developments and Implications for China
It is a great challenge to ensure medication safety in healthcare for older adults, since polypharmacy in this group may increase the risk of potentially inappropriate medications, leading to adverse drug reactions, drug-drug interactions, hospitalizations, increased medical costs, and even deaths....
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Chinese General Practice Publishing House Co., Ltd
2022-05-01
|
| Series: | Zhongguo quanke yixue |
| Subjects: | |
| Online Access: | https://www.chinagp.net/fileup/1007-9572/PDF/yx20220160.pdf |
| _version_ | 1797217239808606208 |
|---|---|
| author | Yuanyuan XU, Zhijie XU, Yating NI, Xujian LIANG, Xueting HU, Zheming FANG, Yue ZHU, Lizheng FANG |
| author_facet | Yuanyuan XU, Zhijie XU, Yating NI, Xujian LIANG, Xueting HU, Zheming FANG, Yue ZHU, Lizheng FANG |
| author_sort | Yuanyuan XU, Zhijie XU, Yating NI, Xujian LIANG, Xueting HU, Zheming FANG, Yue ZHU, Lizheng FANG |
| collection | DOAJ |
| description | It is a great challenge to ensure medication safety in healthcare for older adults, since polypharmacy in this group may increase the risk of potentially inappropriate medications, leading to adverse drug reactions, drug-drug interactions, hospitalizations, increased medical costs, and even deaths. Deprescribing improves patient prognosis and reduces adverse drug events through patient participation, and shared decision-making. The prevalence of multimorbidity and polypharmacy in older adults is notably in community care, the frontline for the management of use of multiple drugs. As primary care physicians have a deep understanding of patients' past and current diagnoses and treatments, they play a vital role in reviewing and managing patients' medications. However, there are few reports on deprescribing in primary care in China. We described the definition of deprescribing, and reviewed its recent advances, with a focus on the implementation process of deprescribing in the community, and the impact of deprescribing on chronic disease management by primary care physicians. This review may provide a reference for further study and policy making regarding deprescribing in the community in China. |
| first_indexed | 2024-04-24T11:58:42Z |
| format | Article |
| id | doaj.art-70674001bf9b4ea5bc84072a54c0e9e9 |
| institution | Directory Open Access Journal |
| issn | 1007-9572 |
| language | zho |
| last_indexed | 2024-04-24T11:58:42Z |
| publishDate | 2022-05-01 |
| publisher | Chinese General Practice Publishing House Co., Ltd |
| record_format | Article |
| series | Zhongguo quanke yixue |
| spelling | doaj.art-70674001bf9b4ea5bc84072a54c0e9e92024-04-09T03:11:43ZzhoChinese General Practice Publishing House Co., LtdZhongguo quanke yixue1007-95722022-05-0125131557156310.12114/j.issn.1007-9572.2022.0160Deprescribing for Older Adults in the Community: Recent Developments and Implications for ChinaYuanyuan XU, Zhijie XU, Yating NI, Xujian LIANG, Xueting HU, Zheming FANG, Yue ZHU, Lizheng FANG01. Department of General Practice, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China;2. Department of General Practice, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, ChinaIt is a great challenge to ensure medication safety in healthcare for older adults, since polypharmacy in this group may increase the risk of potentially inappropriate medications, leading to adverse drug reactions, drug-drug interactions, hospitalizations, increased medical costs, and even deaths. Deprescribing improves patient prognosis and reduces adverse drug events through patient participation, and shared decision-making. The prevalence of multimorbidity and polypharmacy in older adults is notably in community care, the frontline for the management of use of multiple drugs. As primary care physicians have a deep understanding of patients' past and current diagnoses and treatments, they play a vital role in reviewing and managing patients' medications. However, there are few reports on deprescribing in primary care in China. We described the definition of deprescribing, and reviewed its recent advances, with a focus on the implementation process of deprescribing in the community, and the impact of deprescribing on chronic disease management by primary care physicians. This review may provide a reference for further study and policy making regarding deprescribing in the community in China.https://www.chinagp.net/fileup/1007-9572/PDF/yx20220160.pdfdeprescribing|elderly|primary health care|polypharmacy|review |
| spellingShingle | Yuanyuan XU, Zhijie XU, Yating NI, Xujian LIANG, Xueting HU, Zheming FANG, Yue ZHU, Lizheng FANG Deprescribing for Older Adults in the Community: Recent Developments and Implications for China Zhongguo quanke yixue deprescribing|elderly|primary health care|polypharmacy|review |
| title | Deprescribing for Older Adults in the Community: Recent Developments and Implications for China |
| title_full | Deprescribing for Older Adults in the Community: Recent Developments and Implications for China |
| title_fullStr | Deprescribing for Older Adults in the Community: Recent Developments and Implications for China |
| title_full_unstemmed | Deprescribing for Older Adults in the Community: Recent Developments and Implications for China |
| title_short | Deprescribing for Older Adults in the Community: Recent Developments and Implications for China |
| title_sort | deprescribing for older adults in the community recent developments and implications for china |
| topic | deprescribing|elderly|primary health care|polypharmacy|review |
| url | https://www.chinagp.net/fileup/1007-9572/PDF/yx20220160.pdf |
| work_keys_str_mv | AT yuanyuanxuzhijiexuyatingnixujianliangxuetinghuzhemingfangyuezhulizhengfang deprescribingforolderadultsinthecommunityrecentdevelopmentsandimplicationsforchina |